Position in LQDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,301,220
New position
Shares Held
41,405
first reported quarter
Ownership
0.046%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#100
of 333 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Penserra Capital Management LLC holds $11,877,521 across 6 Drug Manufacturers - Specialty & Generic names. LQDA ranks #2 (27.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
101,095 | $3,504,963 | |
| 2 | LQDA |
Liquidia Corp
This page
|
41,405 | $3,301,220 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
30,226 | $1,932,952 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
43,098 | $1,768,310 | |
| 5 | ZTS |
Zoetis Inc.
|
18,632 | $1,336,310 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
726 | $33,766 |
All Filings in LQDA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,301,220 | 41,405 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||